Dr Peter Higgins

  • Honorary Clinical Teacher (Undergraduate Medical School)

Publications

List by: Type | Date

Jump to: 2016 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008
Number of items: 19.

2016

MacIsaac, R., Janek, S., Higgins, P., Walters, M. R. , Padmanabhan, S. , Dominiczak, A. F. , Touyz, R. M. and Dawson, J. (2016) Allopurinol and cardiovascular outcomes in adults with hypertension. Hypertension, 67(3), pp. 535-540. (doi: 10.1161/HYPERTENSIONAHA.115.06344) (PMID:26865199)

2014

Beattie, C. J., Fulton, R. L., Higgins, P., Padmanabhan, S. , McCallum, L., Walters, M. R. , Dominiczak, A. F. , Touyz, R. M. and Dawson, J. (2014) Allopurinol initiation and change in blood pressure in older adults with hypertension. Hypertension, 64(5), pp. 1102-1107. (doi: 10.1161/HYPERTENSIONAHA.114.03953) (PMID:25135183)

Higgins, P., Walters, M. R. , Murray, H. M., McArthur, K., McConnachie, A. , Lees, K. R. and Dawson, J. (2014) Allopurinol reduces brachial and central blood pressure, and carotid intima-media thickness progression after ischaemic stroke and transient ischaemic attack: a randomised controlled trial. Heart, 100(14), pp. 1085-1092. (doi: 10.1136/heartjnl-2014-305683)

Higgins, P., Dawson, J. , Macfarlane, P. W., McArthur, K., Langhorne, P. and Lees, K. R. (2014) Predictive value of newly detected atrial fibrillation paroxysms in patients with acute ischemic stroke, for atrial fibrillation after 90 days. Stroke, 45(7), pp. 2134-2136. (doi: 10.1161/STROKEAHA.114.005405)

2013

Morgan, T.C. et al. (2013) The modified graeb score: an enhanced tool for intraventricular hemorrhage measurement and prediction of functional outcome. Stroke, 44(3), pp. 635-641. (doi: 10.1161/STROKEAHA.112.670653)

Higgins, P., Macfarlane, P. W., Dawson, J. , McInnes, G. T., Langhorne, P. and Lees, K. R. (2013) Noninvasive cardiac event monitoring to detect atrial fibrillation after ischemic stroke: a randomized, controlled trial. Stroke, 44(9), pp. 2525-2531. (doi: 10.1161/STROKEAHA.113.001927)

McArthur, K.S., Johnson, P.C.D. , Quinn, T. , Higgins, P., Langhorne, P. , Walters, M.R. , Weir, C.J., Dawson, J. and Lees, K.R. (2013) Improving the efficiency of stroke trials: feasibility and efficacy of group adjudication of functional end points. Stroke, 14(12), pp. 3422-3428. (doi: 10.1161/STROKEAHA.113.002266)

2012

Traylor, M. et al. (2012) Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): a meta-analysis of genome-wide association studies. Lancet Neurology, 11(11), pp. 951-962. (doi: 10.1016/S1474-4422(12)70234-X)

Paul, L. et al. (2012) Hematocrit predicts long-term mortality in a nonlinear and sex-specific manner in hypertensive adults. Hypertension, 60(3), pp. 631-638. (doi: 10.1161/HYPERTENSIONAHA.112.191510)

Higgins, P., Dawson, J. , Lees, K.R., McArthur, K., Quinn, T.J. and Walters, M.R. (2012) Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis. Cardiovascular Therapeutics, 30(4), pp. 217-226. (doi: 10.1111/j.1755-5922.2011.00277.x)

Kerr, D.M., Fulton, R.L., Higgins, P., Bath, P.M.W., Shuaib, A., Lyden, P. and Lees, K.R. (2012) Response of blood pressure and blood glucose to treatment with recombinant tissue-type plasminogen activator in acute ischemic stroke: evidence from the virtual international stroke trials archive. Stroke, 43(2), pp. 399-404. (doi: 10.1161/STROKEAHA.111.627059)

2011

Favilla, C. G., Mullen, M. T., Ali, M. , Higgins, P. and Kasner, S. E. (2011) Sulfonylurea Use Before Stroke Does Not Influence Outcome. Stroke, 42(3), pp. 710-715. (doi: 10.1161/STROKEAHA.110.599274)

Higgins, P., Dawson, J. and Walters, M. (2011) Nanomedicine: Nanotubes reduce stroke damage. Nature Nanotechnology, 6(6), pp. 83-84. (doi: 10.1038/nnano.2011.5)

Higgins, P., Ferguson, L. D. and Walters, M. R. (2011) Xanthine oxidase inhibition for the treatment of stroke disease: a novel therapeutic approach. Expert Review of Cardiovascular Therapy, 9(4), pp. 399-401. (doi: 10.1586/erc.11.29) (PMID:21517722)

Kerr, G.D., Higgins, P., Walters, M. , Ghosh, S.K., Wright, F., Langhorne, P. and Stott, D.J. (2011) Socioeconomic status and transient ischaemic attack / stroke: a prospective observational study. Cerebrovascular Diseases, 31(2), pp. 130-137. (doi: 10.1159/000321732)

McArthur, K.S., Quinn, T.J. , Higgins, P. and Langhorne, P. (2011) Post-acute care and secondary prevention after ischaemic stroke. British Medical Journal, 342, d2083-d2083. (doi: 10.1136/bmj.d2083)

2010

Dawson, J. , Quinn, T.J. , Rafferty, M., Higgins, P., Ray, G., Lees, K.R. and Walters, M.R. (2010) Aspirin resistance and compliance with therapy. Cardiovascular Therapeutics, 29(5), pp. 301-307. (doi: 10.1111/j.1755-5922.2010.00188.x)

2009

Higgins, P. and Lees, K.R. (2009) Advances in emerging therapies 2008. Stroke, 40(5), e292-e294. (doi: 10.1161/STROKEAHA.108.544544)

2008

Higgins, P., Ghosh, S. and Lees, K. (2008) Improving mortality from stroke disease: putting the evidence into practice. British Journal of Hospital Medicine, 69(12), pp. 668-669.

This list was generated on Mon Apr 22 16:11:39 2024 BST.
Jump to: Articles
Number of items: 19.

Articles

MacIsaac, R., Janek, S., Higgins, P., Walters, M. R. , Padmanabhan, S. , Dominiczak, A. F. , Touyz, R. M. and Dawson, J. (2016) Allopurinol and cardiovascular outcomes in adults with hypertension. Hypertension, 67(3), pp. 535-540. (doi: 10.1161/HYPERTENSIONAHA.115.06344) (PMID:26865199)

Beattie, C. J., Fulton, R. L., Higgins, P., Padmanabhan, S. , McCallum, L., Walters, M. R. , Dominiczak, A. F. , Touyz, R. M. and Dawson, J. (2014) Allopurinol initiation and change in blood pressure in older adults with hypertension. Hypertension, 64(5), pp. 1102-1107. (doi: 10.1161/HYPERTENSIONAHA.114.03953) (PMID:25135183)

Higgins, P., Walters, M. R. , Murray, H. M., McArthur, K., McConnachie, A. , Lees, K. R. and Dawson, J. (2014) Allopurinol reduces brachial and central blood pressure, and carotid intima-media thickness progression after ischaemic stroke and transient ischaemic attack: a randomised controlled trial. Heart, 100(14), pp. 1085-1092. (doi: 10.1136/heartjnl-2014-305683)

Higgins, P., Dawson, J. , Macfarlane, P. W., McArthur, K., Langhorne, P. and Lees, K. R. (2014) Predictive value of newly detected atrial fibrillation paroxysms in patients with acute ischemic stroke, for atrial fibrillation after 90 days. Stroke, 45(7), pp. 2134-2136. (doi: 10.1161/STROKEAHA.114.005405)

Morgan, T.C. et al. (2013) The modified graeb score: an enhanced tool for intraventricular hemorrhage measurement and prediction of functional outcome. Stroke, 44(3), pp. 635-641. (doi: 10.1161/STROKEAHA.112.670653)

Higgins, P., Macfarlane, P. W., Dawson, J. , McInnes, G. T., Langhorne, P. and Lees, K. R. (2013) Noninvasive cardiac event monitoring to detect atrial fibrillation after ischemic stroke: a randomized, controlled trial. Stroke, 44(9), pp. 2525-2531. (doi: 10.1161/STROKEAHA.113.001927)

McArthur, K.S., Johnson, P.C.D. , Quinn, T. , Higgins, P., Langhorne, P. , Walters, M.R. , Weir, C.J., Dawson, J. and Lees, K.R. (2013) Improving the efficiency of stroke trials: feasibility and efficacy of group adjudication of functional end points. Stroke, 14(12), pp. 3422-3428. (doi: 10.1161/STROKEAHA.113.002266)

Traylor, M. et al. (2012) Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): a meta-analysis of genome-wide association studies. Lancet Neurology, 11(11), pp. 951-962. (doi: 10.1016/S1474-4422(12)70234-X)

Paul, L. et al. (2012) Hematocrit predicts long-term mortality in a nonlinear and sex-specific manner in hypertensive adults. Hypertension, 60(3), pp. 631-638. (doi: 10.1161/HYPERTENSIONAHA.112.191510)

Higgins, P., Dawson, J. , Lees, K.R., McArthur, K., Quinn, T.J. and Walters, M.R. (2012) Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis. Cardiovascular Therapeutics, 30(4), pp. 217-226. (doi: 10.1111/j.1755-5922.2011.00277.x)

Kerr, D.M., Fulton, R.L., Higgins, P., Bath, P.M.W., Shuaib, A., Lyden, P. and Lees, K.R. (2012) Response of blood pressure and blood glucose to treatment with recombinant tissue-type plasminogen activator in acute ischemic stroke: evidence from the virtual international stroke trials archive. Stroke, 43(2), pp. 399-404. (doi: 10.1161/STROKEAHA.111.627059)

Favilla, C. G., Mullen, M. T., Ali, M. , Higgins, P. and Kasner, S. E. (2011) Sulfonylurea Use Before Stroke Does Not Influence Outcome. Stroke, 42(3), pp. 710-715. (doi: 10.1161/STROKEAHA.110.599274)

Higgins, P., Dawson, J. and Walters, M. (2011) Nanomedicine: Nanotubes reduce stroke damage. Nature Nanotechnology, 6(6), pp. 83-84. (doi: 10.1038/nnano.2011.5)

Higgins, P., Ferguson, L. D. and Walters, M. R. (2011) Xanthine oxidase inhibition for the treatment of stroke disease: a novel therapeutic approach. Expert Review of Cardiovascular Therapy, 9(4), pp. 399-401. (doi: 10.1586/erc.11.29) (PMID:21517722)

Kerr, G.D., Higgins, P., Walters, M. , Ghosh, S.K., Wright, F., Langhorne, P. and Stott, D.J. (2011) Socioeconomic status and transient ischaemic attack / stroke: a prospective observational study. Cerebrovascular Diseases, 31(2), pp. 130-137. (doi: 10.1159/000321732)

McArthur, K.S., Quinn, T.J. , Higgins, P. and Langhorne, P. (2011) Post-acute care and secondary prevention after ischaemic stroke. British Medical Journal, 342, d2083-d2083. (doi: 10.1136/bmj.d2083)

Dawson, J. , Quinn, T.J. , Rafferty, M., Higgins, P., Ray, G., Lees, K.R. and Walters, M.R. (2010) Aspirin resistance and compliance with therapy. Cardiovascular Therapeutics, 29(5), pp. 301-307. (doi: 10.1111/j.1755-5922.2010.00188.x)

Higgins, P. and Lees, K.R. (2009) Advances in emerging therapies 2008. Stroke, 40(5), e292-e294. (doi: 10.1161/STROKEAHA.108.544544)

Higgins, P., Ghosh, S. and Lees, K. (2008) Improving mortality from stroke disease: putting the evidence into practice. British Journal of Hospital Medicine, 69(12), pp. 668-669.

This list was generated on Mon Apr 22 16:11:39 2024 BST.